Article info

Download PDFPDF
Gemcitabine and Vinorelbine Combination in Platinum-Sensitive Recurrent Ovarian Cancer

Authors

  • Annamaria Ferrero Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment (IRCC) of Candiolo and AO Ordine Mauriziano, Turin, Italy. PubMed articlesGoogle scholar articles
  • Vilma Logrippo Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment (IRCC) of Candiolo and AO Ordine Mauriziano, Turin, Italy. PubMed articlesGoogle scholar articles
  • Pier Giorgio Spanu Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment (IRCC) of Candiolo and AO Ordine Mauriziano, Turin, Italy. PubMed articlesGoogle scholar articles
  • Luca Fuso Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment (IRCC) of Candiolo and AO Ordine Mauriziano, Turin, Italy. PubMed articlesGoogle scholar articles
  • Stefania Perotto Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment (IRCC) of Candiolo and AO Ordine Mauriziano, Turin, Italy. PubMed articlesGoogle scholar articles
  • Alberto Daniele Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment (IRCC) of Candiolo and AO Ordine Mauriziano, Turin, Italy. PubMed articlesGoogle scholar articles
  • Paolo Zola Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment (IRCC) of Candiolo and AO Ordine Mauriziano, Turin, Italy. PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Annamaria Ferrero, MD, PhD, Via Carducci, 20-10044 Pianezza, Turin, Italy. E-mail: a.ferrero{at}katamail.com.

Citation

Ferrero A, Logrippo V, Spanu PG, et al
Gemcitabine and Vinorelbine Combination in Platinum-Sensitive Recurrent Ovarian Cancer

Publication history

  • First published November 1, 2009.
Online issue publication 
November 01, 2009

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.